logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Neural Tube Defects

    FiltersReset Filters
    4 results

    • drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium

      (drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium)
      Lupin Pharmaceuticals, Inc.
      Usage: Drospirenone, ethinyl estradiol, and levomefolate calcium tablets are indicated for preventing pregnancy, treating premenstrual dysphoric disorder (PMDD), moderate acne in females of reproductive potential, and providing folate supplementation to reduce neural tube defect risks in pregnancies conceived while using or shortly after discontinuing the medication.

    • drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium

      (Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium)
      Sandoz Inc
      Usage: Drospirenone/Ethinyl Estradiol/Levomefolate Calcium is indicated for females of reproductive potential to prevent pregnancy and to raise folate levels, reducing the risk of neural tube defects in pregnancies conceived during or shortly after use.

    • safyral

      (Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Safyral is indicated for females of reproductive potential to prevent pregnancy and to raise folate levels, reducing the risk of neural tube defects in pregnancies conceived while using the product or shortly after discontinuation.

    • tydemy

      (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium and Levomefolate Calcium)
      Lupin Pharmaceuticals, Inc.
      Usage: Tydemy™ is indicated for females of reproductive potential to prevent pregnancy and for folate supplementation to reduce the risk of neural tube defects in pregnancies conceived while using the product or shortly after discontinuation.